Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q4 FY24 results · Jan–Mar 2024

Krsnaa Diagnostics reported revenue from operations of ₹166.28 crore (up 24.8% from Q4 FY23) and net profit of ₹18.73 crore (down 1.0% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations166.28133.23+24.8%158.32+5.0%
Other income4.345.93−26.8%4.08+6.4%
Total income170.62139.15+22.6%162.40+5.1%
Profit before tax22.6123.58−4.1%16.09+40.4%
Net profit for the period18.7318.92−1.0%12.97+44.3%
EPS, basic (₹)5.806.03−3.8%4.09+41.8%
Net margin (%)11.314.28.2
Standalone · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations159.33115.86+37.5%151.55+5.1%
Other income4.345.94−26.9%4.08+6.4%
Total income163.67121.80+34.4%155.63+5.2%
Profit before tax22.1814.20+56.2%16.87+31.5%
Net profit for the period18.4211.81+56.0%13.59+35.6%
EPS, basic (₹)5.703.76+51.6%4.28+33.2%
Net margin (%)11.610.29.0
Consolidated
Filed with BSE
05 Jun 2024, 12:18 IST
Board meeting
18 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
05 Jun 2024, 12:18 IST
Board meeting
18 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE